Affiliation: Imperial College
- Iron, haemochromatosis and thalassaemia as risk factors for fibrosis in hepatitis C virus infectionMark Thursz
Gastroenterology and Hepatology Research, Imperial College St Mary's Hospital Campus, Norfolk Place, London W2 1NY, UK
Gut 56:613-4. 2007
- Understanding the host genetics of chronic hepatitis B and CMark Thursz
Hepatology and Gastroenterology Section, Department of Medicine, Imperial College, London, United Kingdom
Semin Liver Dis 31:115-27. 2011..Indeed, stratification of clinical trial populations based on IL-28B genotype is already considered mandatory...
- Blunted increase in serum hepcidin as response to oral iron in HFE-hemochromatosisArvind Sangwaiya
Department of Gastroenterology, Ealing Hospital NHS Trust, London, UK
Eur J Gastroenterol Hepatol 23:721-4. 2011..However, the precise link between hepcidin levels and iron absorption in HFE-H patients has been poorly understood...
- NICE guidelines and a treatment algorithm for the management of chronic hepatitis B: a review of 12 years experience in west LondonPatrick T F Kennedy
Department of Hepatology, Imperial College London at St Mary s Hospital, London, UK
Antivir Ther 13:1067-76. 2008....
- Quantitative versus morphological assessment of liver fibrosis: semi-quantitative scores are more robust than digital image fibrosis area estimationMark Wright
Hepatology Section, Faculty of Medicine, Imperial College, London W2 1NY, UK
Liver Int 23:28-34. 2003..Accurate determination of a threshold greyscale level representing fibrous tissue is critical. This method has not been fully evaluated in clinical practice...
- Association of genetic variants of the chemokine receptor CCR5 and its ligands, RANTES and MCP-2, with outcome of HCV infectionSimon Hellier
The Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, United Kingdom
Hepatology 38:1468-76. 2003..018, OR: 2.29, 95% CI: 1.14-4.58). In conclusion, our study suggests a possible role of the polymorphisms CCR5-delta32, RANTES -403, and MCP-2 Q46K in the outcome of HCV infection...
- Autoregulatory role of interleukin-10 in hepatitis C patients treated with IFN-alphaArmin Luik
University of Mainz, Department of Medicine, 55101 Mainz, Germany
J Interferon Cytokine Res 24:585-93. 2004..This suggests an autoregulatory role of IL-10 in IFN therapy...